News

Charles Russell Speechlys has acted for the shareholders on the sale of Alphr Technology to Indutrade AB (publ), a company listed on Nasdaq Stockholm.

Alphr Technology designs and manufactures customized equipment for manual and automated production lines. Their portfolio extends from simple mechanical Poka-yoke assembly stations to semi-automatic assembly and test stations, robotic manufacturing cells, rotary machines and even fully automated palletized production lines. Customers are primarily in the automotive industry, and 75% of sales are exported.

The company will be part of Indutrade’s Special Products business area. Indutrade markets and sells components, systems and services with a high-tech content within selected niches. Indutrade’s business is distinguished by high-tech products for recurring needs; growth through a structured and tried and tested acquisition strategy; and a decentralised organisation characterised by entrepreneurial spirit.

Speaking of the deal, Kalli Basra, the CEO of Alphr Technology said, “It was a pleasure to work with Mark Howard and his team at Charles Russell Speechlys. The depth of commercial awareness, technical legal expertise, responsiveness and ability to translate complex issues into points we could understand and digest made the transaction run smoothly and to timetable. We would not hesitate to recommend them to others considering a company sale.”

Commenting on the transaction, Mark Howard, Corporate partner said, “We thoroughly enjoyed working with Kalli and his team on what was a landmark transaction for them personally following many years of dedication and hard work building a successful business with blue chip clients and worldwide sales. We wish them well for the future and hope to be able to work with them again.”

Join us on

We would like to place strictly necessary cookies and performance cookies on your computer to improve our website service. To find out more about how we use cookies and how you can change your cookies settings, please read our cookie statement. Otherwise, we'll assume you are OK to continue.